| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 106.456 | 126.028 | 150.018 | 169.154 | 153.540 | 159.201 | 183.737 | 236.796 | 249.175 | 230.906 |
| Total Income - EUR | 106.551 | 126.200 | 150.439 | 172.764 | 155.899 | 159.352 | 183.763 | 237.021 | 249.303 | 231.889 |
| Total Expenses - EUR | 98.980 | 119.680 | 155.252 | 171.996 | 148.843 | 151.447 | 183.877 | 226.271 | 242.566 | 234.539 |
| Gross Profit/Loss - EUR | 7.571 | 6.519 | -4.813 | 768 | 7.056 | 7.905 | -114 | 10.749 | 6.736 | -2.650 |
| Net Profit/Loss - EUR | 6.333 | 5.440 | -5.785 | 340 | 5.915 | 6.778 | -278 | 8.838 | 5.487 | -2.772 |
| Employees | 1 | 3 | 4 | 3 | 2 | 2 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Crismi Vioprim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 6.878 | 4.720 | 2.534 | 12.170 |
| Current Assets | 13.172 | 27.381 | 64.165 | 55.888 | 58.169 | 66.370 | 66.272 | 68.300 | 61.111 | 54.589 |
| Inventories | 9.464 | 16.253 | 49.212 | 43.545 | 36.880 | 37.463 | 44.003 | 51.851 | 53.625 | 49.302 |
| Receivables | 2.014 | 418 | 5.410 | 3.104 | 783 | 349 | 88 | 2.617 | 3.070 | 990 |
| Cash | 1.694 | 10.710 | 9.543 | 9.239 | 20.507 | 28.558 | 22.180 | 13.832 | 4.416 | 4.297 |
| Shareholders Funds | 4.773 | 10.165 | 7.146 | 7.354 | 13.126 | 19.986 | 13.520 | 18.328 | 16.068 | 13.206 |
| Social Capital | 45 | 45 | 9.895 | 9.713 | 9.525 | 9.344 | 9.137 | 9.166 | 9.138 | 9.087 |
| Debts | 8.399 | 17.217 | 57.020 | 48.534 | 45.043 | 46.384 | 59.630 | 54.692 | 47.577 | 53.553 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Crismi Vioprim Srl